These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 4679248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Tolerance test of HB 419 in animal experiments].
    Hebold G, Scholz J, Schütz E, Czerwek H, Brunk R.
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1404-13. PubMed ID: 5394461
    [No Abstract] [Full Text] [Related]

  • 3. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J, Cordes U, Sell G, Schöffling K.
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Toxicological studies of N-4-2-(5-chloro-2-methoxybenzamido)-ethyl-phenylsulfonyl-n'-cyclohexylurea (HB 419)].
    Mizukami K, Miyamoto M, Hayashi S, Kobayashi T, Sakurai M, Sakaguchi T.
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1413-9. PubMed ID: 5395701
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Toxicological study on bamifylline.
    Georges A, Dusart P, Gerin Y, Denef J.
    Arzneimittelforschung; 1968 Apr; 18(4):460-6. PubMed ID: 5754939
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Blood sugar reducing sulfonylureas with substituted cyclohexyl rest].
    Weyer R, Weber H, Aumüller W, Korger G, Muth K, Pfaff W, Bänder A.
    Arzneimittelforschung; 1969 Feb; 19(2):140-3. PubMed ID: 5818749
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of oral hypoglycemic agents.
    Seltzer HS.
    Annu Rev Med; 1980 Feb; 31():261-72. PubMed ID: 6994611
    [No Abstract] [Full Text] [Related]

  • 18. Glypentide: a new hypoglycaemic agent.
    Morell J.
    Biochem Pharmacol; 1974 Oct 15; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract] [Full Text] [Related]

  • 19. [Glisolamide, a new sulfanylurea. Pharmacologic characteristics].
    D'Alò G, Dalla Vedova R, Cadel S, Campi G, Wassermann A.
    Boll Chim Farm; 1978 Jun 15; 117(6):348-67. PubMed ID: 743381
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.